INDO US BIOTECH
Back to Balance Sheet
|
INDO US BIOTECH Last 5 Year Net Current Assets History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹70 Cr | ₹56 Cr | ₹48 Cr | ₹35 Cr | ₹20 Cr |
What is the latest Net Current Assets ratio of INDO US BIOTECH ?
| Year | Net Current Assets |
|---|---|
| Mar2025 | ₹70 Cr |
| Mar2024 | ₹56 Cr |
| Mar2023 | ₹48 Cr |
| Mar2022 | ₹35 Cr |
| Mar2021 | ₹20 Cr |
How is Net Current Assets of INDO US BIOTECH Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹70 Cr | 26.54 | |
| Mar2024 | ₹56 Cr | 16.82 | |
| Mar2023 | ₹48 Cr | 36.64 | |
| Mar2022 | ₹35 Cr | 72.77 | |
| Mar2021 | ₹20 Cr | - | |
Compare Net Current Assets of peers of INDO US BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDO US BIOTECH | ₹202.1 Cr | -26.4% | -20.1% | -48% | Stock Analytics | |
| BOMBAY BURMAH TRADING CORPORATION | ₹10,893.1 Cr | -0.4% | -12.1% | -9.1% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹4,150.9 Cr | 12.7% | -9.4% | -24.4% | Stock Analytics | |
| VENKYS (INDIA) | ₹1,830.9 Cr | 3.2% | -18.8% | -22.5% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹881.6 Cr | 0.2% | -8.4% | -35.8% | Stock Analytics | |
| MANGALAM GLOBAL ENTERPRISE | ₹336.5 Cr | 3.3% | -17.1% | -36.7% | Stock Analytics | |
INDO US BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDO US BIOTECH | -26.4% |
-20.1% |
-48% |
| SENSEX | -2.5% |
-6.1% |
7% |
You may also like the below Video Courses